ru 24926 has been researched along with adenosine in 1 studies
Studies (ru 24926) | Trials (ru 24926) | Recent Studies (post-2010) (ru 24926) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
30 | 0 | 0 | 32,536 | 1,075 | 8,930 |
Protein | Taxonomy | ru 24926 (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kelly, E; Nahorski, SR | 1 |
1 other study(ies) available for ru 24926 and adenosine
Article | Year |
---|---|
Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Alprostadil; Animals; Benzazepines; Carbachol; Cholera Toxin; Corpus Striatum; Cyclic AMP; Isoproterenol; Morphine; Phenethylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Receptors, Opioid; Vasoactive Intestinal Peptide | 1986 |